Regulatory Update #271

31 May 2018

Investing in our digital service delivery

In Budget 2018 the Australian Government announced an investment of $10.1 million over three years to enhance our digital capability through the implementation of our digital strategy.

The digital strategy outlines our vision for a modern, digitally enabled regulator by 2022 and provides the framework for investment in an enabling technology program. A new business operating model, supported by modern technology will enable us to maintain and improve organisational performance, better respond to the expectations of clients and stakeholders and client and stakeholder satisfaction levels.

Regulatory decision on polihexanide now available

Polihexanide is an antimicrobial chemical used in swimming pools and spas to control microorganisms. It is also used in veterinary practice and animal houses as a disinfectant, and as a germicide for treating cats, dogs and horses.

We recently published our regulatory decisions on polihexanide following a review, and stakeholder consultation. The review found that polihexanide product registrations can continue, with labels updated to reflect strengthened first aid instructions and safety directions. You can read all of the details about the polihexanide chemical review on our website.

Our response to European Union concerns over neonicotinoids

The European Union (EU) Commission has voted to restrict the use of three neonicotinoid compounds—imidacloprid, clothiandin and thiamethoxam. We will not be initiating a review into registered neonicotinoids used in Australia at this point.

The EU's decision was based on concerns that neonicotinoids may be contributing to a decline in Europe’s honey bee population. The reasons for this decline, including nutrition, environment and disease issues, are currently not a concern to Australia's honey bee population. The information available for Australia indicates that managed and wild honey bee populations are not in decline.

We understand the important role that bees play in Australian agriculture and ecosystems. We will continue to monitor the issue and work with Australia’s honey bee industry to consider the impacts of pesticides on bees.

CEO provides updates on our performance and technology improvements

Our Chief Executive Officer, Dr Chris Parker, provided an update on our performance and planned information communication technology improvements in his opening address at the May budget estimates of the Rural and Regional Affairs and Transport Legislation Committee.

Our performance statistics have improved for the third consecutive quarter, with
79 per cent of assessments finalised on time during the March quarter. A total of 832 applications were finalised by the APVMA between January and March this year.

You can read the full statement from the CEO on our website. 

Reminder—open for public consultation

We regularly seek input throughout chemical registration and review processes, and other operational and regulatory processes. We are currently seeking input on the following open consultations:

Contact us

Australian Pesticides and Veterinary Medicines Authority
PO Box 6182
Kingston, Australian Capital Territory 2604
Australia

Add us to your address book

To protect your privacy, please do not include contact information in your feedback. If you would like a response, please contact us.